DMT-2'O-MOE-RG(IB) PHOSPHORAMIDITE
UNII YG22VT9RHN

Substance Identification & Data

This profile provides standardized clinical and technical data for Dmt-2'o-moe-rg(ib) Phosphoramidite, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YG22VT9RHN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 251647-55-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YG22VT9RHN

CAS Registry Number

251647-55-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DMT-2'O-MOE-RG(IB) PHOSPHORAMIDITE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C47H60N7O10P

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LADCDGNEBIQAAU-SBCRAQIVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

136745830

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(OC[C@@H]1[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](OCCOC)[C@@H](O1)n2c3c(nc2)c(=O)nc(NC(C(C)C)=O)[nH]3)(c4ccc(OC)cc4)(c5ccc(OC)cc5)c6ccccc6

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dmt-2'o-moe-rg(ib) Phosphoramidite. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

2'-MOE-G(IBU)-3'-PHOSPHORAMIDITE

DMT-2'O-MOE-RG(IB) PHOSPHORAMIDITE

GUANOSINE, 5'-O-(BIS(4-METHOXYPHENYL)PHENYLMETHYL)-2'-O-(2-METHOXYETHYL)-N-(2-METHYL-1-OXOPROPYL)-, 3'-(2-CYANOETHYL BIS(1-METHYLETHYL)PHOSPHORAMIDITE)

GUANOSINE, 5'-O-(BIS(4-METHOXYPHENYL)PHENYLMETHYL)-2'-O-(2-METHOXYETHYL)-N-(2-METHYL-1-OXOPROPYL)-, 3'-(2-CYANOETHYL N,N-BIS(1-METHYLETHYL)PHOSPHORAMIDITE)

N2-ISOBUTYRYL-5'-O-(4, 4'-DIMETHOXYTRITYL)-2'-O-METHOXYETHYL-GUANOSINE-3'-CYANOETHYL PHOSPHORAMIDITE

Systematic Nomenclature

(2R,3R,4R,5R)-2-((BIS(4-METHOXYPHENYL)(PHENYL)METHOXY)METHYL)-5-(2-ISOBUTYRAMIDO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)-4-(2-METHOXYETHOXY)TETRAHYDROFURAN-3-YL (2-CYANOETHYL) DIISOPROPYLPHOSPHORAMIDITE

SYS

N-(9-((2R,3R,4R,5R)-5-((BIS(4-METHOXYPHENYL)-PHENYL-METHOXY)METHYL)-4-(2-CYANOETHOXY-(DIISOPROPYLAMINO)PHOSPHANYL)OXY-3-(2-METHOXYETHOXY)TETRAHYDROFURAN-2-YL)-6-OXO-3H-PURIN-2-YL)-2-METHYL-PROPANAMIDE

SYS

External Clinical & Regulatory Resources

Previous UNIIYG215SEW5T

Next UNIIYG275Y6SG4